SCHEMBL625027

SCHEMBL625027

COc1cncc(-c2cn3nc(NCCCNS(C)(=O)=O)sc3n2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ FYN P06241 7/20 0.41
▸ F2RL3 Q96RI0 4/20 0.41
▸ DYRK1A Q13627 3/20 0.40
▸ DYRK3 O43781 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ ROS1 P08922 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ PRKACA P17612 1/20 0.38
▸ RPS6KB1 P23443 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ AKT1 P31749 1/20 0.38
▸ CLK2 P49760 1/20 0.38
▸ GSK3B P49841 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625026 0.81 FYN (0.64) FYNPIK3CA
SCHEMBL1945374 0.79 FYN (0.64) CA12CA1CA2CA9FYN
SCHEMBL1945354 0.79 FYN (0.51) FYNF2RL3PIK3CG
SCHEMBL625477 0.78 FYN (0.50) CA12CA1CA2CA9FYN
SCHEMBL1945185 0.78 FYN (0.58) CA12CA1CA2CA9FYN
SCHEMBL1945259 0.78 FYN (0.67) CA12CA1CA2CA9FYN
SCHEMBL626625 0.78 PIK3CA (0.43) F2RL3PIK3CGPIK3CACYP3A4
SCHEMBL1945197 0.77 FYN (0.66) CA12CA1CA2CA9FYN
SCHEMBL1945148 0.77 FYN (0.66) CA12CA1CA2CA9FYN
SCHEMBL1944741 0.76 FYN (0.47) FYNF2RL3PIK3CGPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 — — WO disclosed
Send feedback